Current Role of Radiation Therapy in the Management of Malignant Brain Tumors

Hematology/Oncology Clinics of North America

Volumn 20, Issue 2, 2006, Pages 431-453

  Tam Truong, Minh ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; LOMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

BIOPSY; BRAIN METASTASIS; BRAIN TUMOR; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; FOLLOW UP; GLIOMA; HISTOLOGY; HUMAN; NEUROLOGIC EXAMINATION; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIOMA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; THROMBOCYTOPENIA; TUMOR GROWTH; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADULT; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; GLIOMA; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY;

EID: 33646761321     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.01.022     Document Type: Review

References (85)

1. American Cancer Society. Cancer facts and figures 2006. Available at:. http://www.cancer.org
2. Johnson J.D., and Young B. Demographics of brain metastasis. Neurosurg Clin N Am 7 3 (1996) 337-344
3. Zulch K.J. Principles of the new World Health Organization (WHO) classification of brain tumors. Neuroradiology 19 2 (1980) 59-66
4. Central Brain Tumor Registry of the United States. Central Brain Tumor Registry of the United States data, 1998-2002. Available at:. http://www.cbtrus.org
5. Forsyth P.A., and Posner J.B. Headaches in patients with brain tumors: a study of 111 patients. Neurology 43 9 (1993) 1678-1683
6. Law M., Yang S., Wang H., et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24 10 (2003) 1989-1998
7. Law M., Cha S., Knopp E.A., et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222 3 (2002) 715-721
8. Leimgruber A., Ostermann S., Yeon E.J., et al. Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. Int J Radiat Oncol Biol Phys 64 3 (2006) 869-875 [Epub 2005 Oct 13]
9. Padma M.V., Said S., Jacobs M., et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64 3 (2003) 227-237
10. Alavi J.B., Alavi A., Chawluk J., et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62 6 (1988) 1074-1078
11. Bauman G., Lote K., Larson D., et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45 4 (1999) 923-929
12. Pignatti F., van den Bent M., Curran D., et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20 8 (2002) 2076-2084
13. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85 9 (1993) 704-710
14. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 4 (1997) 745-751
15. Donahue B., Scott C.B., Nelson J.S., et al. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 38 5 (1997) 911-914
16. Cairncross J.G., Ueki K., Zlatescu M.C., et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90 19 (1998) 1473-1479
17. Hegi M.E., Diserens A.C., Godard S., et al. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10 6 (2004) 1871-1874
18. Hegi M.E., Diserens A.C., Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 10 (2005) 997-1003
19. Torp S.H. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin Neuropathol 21 6 (2002) 252-257
20. Parkins C.S., Darling J.L., Gill S.S., et al. Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling. Br J Neurosurg 5 3 (1991) 289-298
21. Keles G.E., Lamborn K.R., and Berger M.S. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95 5 (2001) 735-745
22. Claus E.B., Horlacher A., Hsu L., et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103 6 (2005) 1227-1233
23. Karim A.B., Afra D., Cornu P., et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52 2 (2002) 316-324
24. Shaw E., Arusell R., Scheithauer B., et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20 9 (2002) 2267-2276
25. van den Bent M.J., Afra D., de Witte O., et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366 9490 (2005) 985-990
26. Brown P.D., Buckner J.C., O'Fallon J.R., et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. J Clin Oncol 21 13 (2003) 2519-2524
27. Eyre H.J., Crowley J.J., Townsend J.J., et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 78 6 (1993) 909-914
28. Hoang-Xuan K., Capelle L., Kujas M., et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22 15 (2004) 3133-3138
29. van den Bent M.J., Stupp R., Brandes A.A., et al. Current and future trials of the EORTC brain tumor group. Onkologie 27 3 (2004) 246-250
30. Walker M.D., Alexander Jr. E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49 3 (1978) 333-343
31. Hochberg F.H., and Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 30 9 (1980) 907-911
32. Chang C.H., Horton J., Schoenfeld D., et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52 6 (1983) 997-1007
33. Nelson D.F., Curran Jr. W.J., Scott C., et al. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma-possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int J Radiat Oncol Biol Phys 25 2 (1993) 193-207
34. Prados M.D., Wara W.M., Sneed P.K., et al. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 49 1 (2001) 71-77
35. Fitzek M.M., Thornton A.F., Harsh G.T., et al. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial. Int J Radiat Oncol Biol Phys 51 1 (2001) 131-137
36. Sarkaria J.N., Mehta M.P., Loeffler J.S., et al. Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32 4 (1995) 931-941
37. Loeffler J.S., Siddon R.L., Wen P.Y., et al. Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. Radiother Oncol 17 4 (1990) 311-321
38. Nwokedi E.C., DiBiase S.J., Jabbour S., et al. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50 1 (2002) 41-46 [discussion: 46-7]
39. Kondziolka D., Flickinger J.C., Bissonette D.J., et al. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41 4 (1997) 776-783 [discussion: 783-5]
40. Souhami L., Seiferheld W., Brachman D., et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60 3 (2004) 853-860
41. Tsao M.N., Mehta M.P., Whelan T.J., et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 63 1 (2005) 47-55
42. Laperriere N.J., Leung P.M., McKenzie S., et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41 5 (1998) 1005-1011
43. Selker R.G., Shapiro W.R., Burger P., et al. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51 2 (2002) 343-355 [discussion: 355-7]
44. Chan T.A., Weingart J.D., Parisi M., et al. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys 62 4 (2005) 1133-1139
45. Roa W., Brasher P.M., Bauman G., et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22 9 (2004) 1583-1588
46. Bleehen N.M., Wiltshire C.R., Plowman P.N., et al. A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma. Br J Cancer 43 4 (1981) 436-442
47. Deutsch M., Green S.B., Strike T.A., et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16 6 (1989) 1389-1396
48. Fischbach A.J., Martz K.L., Nelson J.S., et al. Long-term survival in treated anaplastic astrocytomas. A report of combined RTOG/ECOG studies. Am J Clin Oncol 14 5 (1991) 365-370
49. Fulton D.S., Urtasun R.C., Shin K.H., et al. Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys 10 9 (1984) 1709-1712
50. Hildebrand J.G. [Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors]. Rev Neurol (Paris) 148 6-7 (1992) 435-440
51. Nelson D.F., Diener-West M., Weinstein A.S., et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. Int J Radiat Oncol Biol Phys 12 10 (1986) 1793-1800
52. Nelson D.F., Schoenfeld D., Weinstein A.S., et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study. Int J Radiat Oncol Biol Phys 9 8 (1983) 1143-1151
53. Shin K.H., Urtasun R.C., Fulton D., et al. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer 56 4 (1985) 758-760
54. Fine H.A., Dear K.B., Loeffler J.S., et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71 8 (1993) 2585-2597
55. Levin V.A., Wara W.M., Davis R.L., et al. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63 2 (1985) 218-223
56. Levin V.A., Silver P., Hannigan J., et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18 2 (1990) 321-324
57. Prados M.D., Scott C., Curran Jr. W.J., et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol 17 11 (1999) 3389-3395
58. Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol 19 2 (2001) 509-518
59. Stupp R., Dietrich P.Y., Ostermann Kraljevic S., et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20 5 (2002) 1375-1382
60. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 10 (2005) 987-996
61. Kelly P.J., Daumas-Duport C., Scheithauer B.W., et al. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62 6 (1987) 450-459
62. Floyd N.S., Woo S.Y., Teh B.S., et al. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 58 3 (2004) 721-726
63. Chan M.F., Schupak K., Burman C., et al. Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme. Med Dosim 28 4 (2003) 261-265
64. Sultanem K., Patrocinio H., Lambert C., et al. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 58 1 (2004) 247-252
65. Xia P., Amols H.I., and Ling C.C.L. Chapter 8. In: Leibel S., and Phillips T. (Eds). Text book of radiation oncology. 2nd edition (2004), WB Saunders, Philadelphia 163-186
66. Breen S.L., Kehagioglou P., Usher C., et al. A comparison of conventional, conformal and intensity-modulated coplanar radiotherapy plans for posterior fossa treatment. Br J Radiol 77 921 (2004) 768-774
67. Suzuki M., Nakamatsu K., Kanamori S., et al. Comparison of outcomes between overlapping structure-based and non-overlapping structure-based optimization for simultaneous integrated boost IMRT for malignant gliomas. Int J Clin Oncol 9 6 (2004) 491-497
68. Xing L., Cotrutz C., Hunjan S., et al. Inverse planning for functional image-guided intensity-modulated radiation therapy. Phys Med Biol 47 20 (2002) 3567-3578
69. Zinkin H.D., Rivard M.J., Mignano J.E., et al. Analysis of dose conformity and normal-tissue sparing using two different IMRT prescription methodologies for irregularly shaped CNS lesions irradiated with the Beak and 1-cm MIMiC collimators. Int J Radiat Oncol Biol Phys 59 1 (2004) 285-292
70. Benedict S.H., Cardinale R.M., Wu Q., et al. Intensity-modulated stereotactic radiosurgery using dynamic micro-multileaf collimation. Int J Radiat Oncol Biol Phys 50 3 (2001) 751-758
71. Voynov G., Kaufman S., Hong T., et al. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 25 6 (2002) 606-611
72. Borgelt B., Gelber R., Kramer S., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6 1 (1980) 1-9
73. Shaw E.G. Radiotherapeutic management of multiple brain metastases: "3000 in 10" whole brain radiation is no longer a "no brainer". Int J Radiat Oncol Biol Phys 45 2 (1999) 253-254
74. Sneed P.K., Lamborn K.R., Forstner J.M., et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys 43 3 (1999) 549-558
75. Sneed P.K., Suh J.H., Goetsch S.J., et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53 3 (2002) 519-526
76. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39 6 (1989) 789-796
77. DeAngelis L.M., Mandell L.R., Thaler H.T., et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24 6 (1989) 798-805
78. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 8 (1990) 494-500
79. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 33 6 (1993) 583-590
80. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78 7 (1996) 1470-1476
81. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280 17 (1998) 1485-1489
82. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 9422 (2004) 1665-1672
83. Kondziolka D., Martin J.J., Flickinger J.C., et al. Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104 12 (2005) 2784-2791
84. Flickinger J.C., Kondziolka D., Lunsford L.D., et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28 4 (1994) 797-802
85. Regine W.F., Huhn J.L., Patchell R.A., et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 52 2 (2002) 333-338